PubMed: PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.. Published 2022 Apr. Source: Nat Med. Authors: Narayan V, Barber-Rotenb
Powered by Quantum Pulse Intelligence